References
Smith DW, Lemli L, Opitz JM: A newly recognized syndrome of multiple congenital anomalis.J. Pediatr 1964; 64: 210–217.
Opitz JM: RSH/SLO (“Smith-Lemli-Opitz”) syndrome: historical, genetic, and developmental considerations.Am J Med Genet 1994; 50: 344–346.
Irons M, Elias ER, Salen Get al. Defective cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome [Letter].Lancet 1993; 47: 1414.
Tint GS, Irons M, Elias ERet al. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome.N Engl J Med 1994; 330: 107–113.
Batta AK, Tint GS, Shefer Set al. Identification of 8-dehydrocholesterol (cholesta 5,8-dien-3-β-ol) in patients with the Smith-Lemli-Opitz syndrome.J Lipid Res 1990; 36: 705–713.
Honda A, Tint GS, Salen Get al. Defective conversion of 7-dehydrocholesyetol to cholesterol in cultured skin fibroblasts from Smith-Lemli-Opitz syndrome homozygotes.J Lipid Res 1995; 36: 1595–1601.
Repetto M, Mazziere JC, Citadelle Det al. Teratogenic effect of the cholesterol synthesis inhibitor AY 9944 on rat embryos in vitro.Teratol 1990; 42: 611–618.
Abuelo DN, Tint GS, Kelly Ret al. Prenatal diagnosis of the Smith-Lemli-Opitz syndrome by the analysis of amniotic fluid sterols.Am J Med Genet 1995; 56: 281–285.
Tint GS, Seller M, Hughes-Benzie Ret al. Markedly increased tissue concentrations of 7-dehydrocholesterol combined with low levels of cholesterol are characteristic of the Smith-Lemli-Opitz syndrome.J Lipid Res 1995; 36: 89–95.
Irons M, Elias ER, Tint GSet al. Abnormal cholesterol metabolism in the Smith-Lemli-Opitz syndrome: report of clinical and biochemical findings in four patients and treatment in one patient.Am J Med Genet 1994; 50: 347–352.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Batta, A.K., Salen, G. Characterization of the biochemical abnormality in the Smith-Lemli-Opitz syndrome. Indian J Pediatr 63, 143–147 (1996). https://doi.org/10.1007/BF02845236
Issue Date:
DOI: https://doi.org/10.1007/BF02845236